Arnold Suhr Netherlands B.V. has been acquired by Active Capital Company
May 2017 — The private shareholders of Arnold Suhr Netherlands B.V. have sold the company to Active Capital Company (ACC).
Founded in 1947, Arnold Suhr is a specialty distributor of ingredients, including quinine, iodine and sports nutrition. The company has a top-3 position in each of its key markets. Its customers include major soft drink producers and pharmaceutical companies. Arnold Suhr has a number of strategic investments together with its suppliers, with joint ventures across the world. The company is headquartered in the Netherlands and has a sales office in China. Arnold Suhr has a yearly turnover of approximately US$40 million and 20 employees.
ACC is an Amsterdam-based independent hands-on private equity firm. ACC invests in companies in the Netherlands with revenues between US$5-80 million and is active in industrial goods and services and technical wholesale. Besides new capital, the firm brings in operational and financial expertise.
Our role in the transaction
Oaklins’ team in the Netherlands acted as M&A advisor to the seller in this transaction.
Talk to the deal team
Related deals
Cibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreGroGlass has been acquired by Apogee Enterprises
Apogee Enterprises, Inc. (Nasdaq: APOG), a leading US provider of architectural building products, services and high-performance coated materials, has acquired GroGlass, a Latvia-based developer and manufacturer of high-performance anti-reflective and UV-protective glass coatings. The acquisition brings GroGlass’ differentiated coating technologies and materials science expertise into Apogee’s performance surfaces segment, broadening its product offering and market reach while expanding its manufacturing and R&D presence in Europe.
Learn more